Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, medical professionals have been overwhelmed by questions beyond the infection itself. In dermatology practice, clinicians have been facing difficulties about the management of chronic immune-mediated skin diseases. Issues arose...

Descripción completa

Detalles Bibliográficos
Autores principales: Patsatsi, Aikaterini, Kyriakou, Aikaterini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834280/
https://www.ncbi.nlm.nih.gov/pubmed/33972053
http://dx.doi.org/10.1016/j.clindermatol.2020.12.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834280/
https://www.ncbi.nlm.nih.gov/pubmed/33972053
http://dx.doi.org/10.1016/j.clindermatol.2020.12.012

Ejemplares similares